High-impact pharmacoepidemiology journals are those considered to be highly influential in their respective fields. The impact factor of pharmacoepidemiology journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of similar kind. It reflects the typical number of citations to recent articles published in science and science journals during a particular year or period, and is usually used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founding father of the Institute for Scientific Information. The impact factor of a journal is evaluated by dividing the amount of current year citations to the source items published therein journal during the previous two years.
Review Article: Pharmacoeconomics: Open Access
Review Article: Pharmacoeconomics: Open Access
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Posters: Journal of Bioanalysis & Biomedicine
Posters: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report